Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It is used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain, and is indicated for long‑term management of chronic inflammatory joint diseases. The product conforms to European Union marketing authorisation standards.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics.

Meloxicam is indicated for several inflammatory and musculoskeletal conditions, acting primarily on the joints and spine.

- Osteoarthritis: reduces joint pain and improves function in degenerative joint disease. - Rheumatoid arthritis: alleviates inflammation and joint damage in autoimmune arthritis. - Ankylosing spondylitis: diminishes spinal stiffness and pain associated with axial spondyloarthritis. - Acute pain: provides short‑term relief of moderate to severe musculoskeletal pain.

Meloxicam may cause a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia. - Headache. - Dizziness. - Peripheral edema. - Elevated blood pressure. - Skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe cutaneous reactions (e.g., Stevens‑Johnson syndrome). - Hepatic injury or elevated liver enzymes. - Renal impairment or acute kidney injury. - Anaphylactic or severe hypersensitivity reactions.

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risk.

- Assess renal function: evaluate baseline creatinine and adjust if impaired. - Monitor hepatic enzymes: check liver function before and during therapy. - Evaluate cardiovascular risk: use cautiously in patients with history of heart disease. - Avoid use in late pregnancy: contraindicated in the third trimester. - Use lowest effective dose: limit duration to the shortest necessary. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function. - Diuretics: risk of renal impairment and electrolyte imbalance. - Lithium: NSAIDs can increase lithium serum levels.